The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...
Each SOP document is a unit of risk,” said Paul Mathews, director of product management at CSC. “When the volume rises, there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback